Statins in Proteinuric Nephropathies

PHASE3CompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

March 31, 2008

Conditions
Chronic NephropathyProteinuriaHypertension
Interventions
DRUG

Fluvastatin

Starting dose of Fluvastatin of 40 mg/day uptitrated to 80 mg/day

DRUG

standard therapy

standard therapy

Trial Locations (16)

24020

Clinical Research Center for Rare Diseases, Ranica

30174

Hospital of Mestre - Unit of Nephrology and Dialysis, Venezia

31033

Hospital of Padova - Unit of Nephrology and Dialysis, Padua

"Hospital S.Giacomo Apostolo", Castelfranco Veneto

43100

Hospital of Parma - Department of Medical Clinic, Parma

50011

"Hospital Santa Maria dell'Annunziata - Unit of Nephrology", Bagno a Ripoli

52100

"Hospital Santa Maria della Gruccia - Unit of Nephrology and Dialysis", Montevarchi

64100

"Hospital G.Mazzini - Unit of Nephrology and Dialysis", Teramo

71013

"Hospital Casa Sollievo della Sofferenza - Unit of Nephrology and Dialysis", San Giovanni Rotondo

88100

"Hospital Ciaccio - Unit of Nephrolofy and Dialysis", Catanzaro

89124

"Ospedali Riuniti CNR I.B.I.M. - Unit of Nephrology", Reggio Calabria

90100

"Hospital Civico e Benefratelli - Unit of Nephrology and Hemodialysis", Palermo

95024

"Hospital S.Marte e S.Venere - Unit of Nephrology and Dialysis", Acireale

95100

"Hospital Vittorio Emanuele II, S. Bambino, Ferrarotto - Unit of Nephrology and Dialisys", Catania

Unknown

"Hospital Careggi Monna Tessa - Unit of Nephrology and Dialysis", Florence

07100

University of Sassari - Institute of Medical Pathology, Sassari

All Listed Sponsors
lead

Mario Negri Institute for Pharmacological Research

OTHER

NCT00199927 - Statins in Proteinuric Nephropathies | Biotech Hunter | Biotech Hunter